NCT03373929 (STITCH) is a NA clinical trial of PFO Closure Rate in Foramen Ovale, Patent, sponsored by HeartStitch.Com.

Who is sponsoring NCT03373929?

NCT03373929 is sponsored by HeartStitch.Com.

What drugs are being tested in NCT03373929?

Interventions in NCT03373929: PFO Closure Rate, Published PFO Device Closure.

What condition does NCT03373929 study?

NCT03373929 studies Foramen Ovale, Patent, Septal Defect, Atrial, Septal Defect, Heart.

Is NCT03373929 still recruiting?

NCT03373929 is currently status unknown. Last updated 14 December 2017.

Last reviewed 2017-12-14 · How we verify

NCT03373929: STITCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stitch Closure of PFO and Septal Repair

Status unknown NA Last updated 14 December 2017

What this trial tests

NA trial testing PFO Closure Rate in Foramen Ovale, Patent in 250 participants. Status unknown.

Timeline

20 November 2017

Primary endpoint
20 November 2019

20 November 2022

Quick facts

Lead sponsor	HeartStitch.Com
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	250
Start date	20 November 2017
Primary completion	20 November 2019
Estimated completion	20 November 2022
Sites	1 location across United States

Drugs / interventions tested

PFO Closure Rate
Published PFO Device Closure

Conditions studied

Foramen Ovale, Patent — all drugs for Foramen Ovale, Patent →
Septal Defect, Atrial — all drugs for Septal Defect, Atrial →
Septal Defect, Heart — all drugs for Septal Defect, Heart →

Sponsor

HeartStitch.Com

Who can join

Adults 18 to 65, any sex, with Foramen Ovale, Patent or Septal Defect, Atrial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the STITCH study is to evaluate closure rates of clinically relevant septal defects, including patent foramen ovale (PFO), Atrial Septal Defects (ASD - less than 1 cm with redundant septal tissue), trans septal puncture sites, repair of Atrial Septal Aneurysm (ASA) and rate of recurrent neurologic embolic events in patients with cryptogenic stroke and PFO.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Foramen Ovale, Patent

Currently open trials in the same condition.

NCT04881578 — Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study · active not recruiting
NCT04339699 — NobleStitch EL STITCH Trial is a PFO Comparative Trial · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03373929 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HeartStitch.Com
Last refreshed: 14 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03373929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing